E2 ModeratePreliminaryPEM not requiredCross-SectionalPeer-reviewedReviewed
A biochemical analysis of people with chronic fatigue who have Irlen Syndrome: speculation concerning immune system dysfunction.
Robinson, G L, McGregor, N R, Roberts, T K et al. · Perceptual and motor skills · 2001 · DOI
Quick Summary
This study looked at 61 people with ME/CFS to see if they also had a visual processing problem called Irlen Syndrome (where certain patterns and lighting cause visual discomfort). Researchers found that people with more severe visual problems had different levels of certain fats and amino acids in their blood and urine compared to those with milder visual symptoms. The authors suggest these differences might show signs of immune system activation, possibly from an infection.
Why It Matters
This study explores a potential biological connection between a common visual processing problem in ME/CFS and immune system dysfunction, which could help explain some ME/CFS symptoms. If validated, metabolic profiling might eventually help doctors better diagnose and categorize ME/CFS, leading to more targeted research and treatment approaches.
Observed Findings
- Significant variations in blood lipid profiles between participants with different severity levels of Irlen Syndrome
- Significant variations in urinary amino acids between the two groups
- Significant variations in urinary organic acids between the two groups
- Co-occurrence of Irlen Syndrome in adults with ME/CFS symptoms
Inferred Conclusions
- Metabolic profiling may help develop more valid diagnostic categories within ME/CFS
- The metabolic variations suggest possible immune system activation in response to an infective agent
- Vascular or metabolic dysfunction may underlie both visual processing problems and ME/CFS symptoms
- Biochemical markers could help distinguish subgroups within ME/CFS populations
Remaining Questions
- Are the observed metabolic differences specific to ME/CFS with Irlen Syndrome, or do they also occur in ME/CFS patients without visual processing problems?
- What is the temporal relationship between visual processing deficits and metabolic changes—do they develop together or sequentially?
- What specific infectious agents, if any, might trigger the immune activation reflected in these metabolic markers?
What This Study Does Not Prove
This study does not prove that Irlen Syndrome causes ME/CFS or that the metabolic differences cause either condition. The cross-sectional design means we cannot determine whether metabolic changes precede or follow visual symptoms, and without a healthy control group, we cannot confirm these markers are specific to ME/CFS or Irlen Syndrome.
Tags
Symptom:FatigueSensory Sensitivity
Biomarker:MetabolomicsBlood Biomarker
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory OnlyPEM Not Defined
Metadata
- DOI
- 10.2466/pms.2001.93.2.486
- PMID
- 11769907
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.